Mk. Offermann et al., ANTIOXIDANT-SENSITIVE REGULATION OF INFLAMMATORY-RESPONSE GENES IN KAPOSIS-SARCOMA CELLS, Journal of acquired immune deficiency syndromes and human retrovirology, 13(1), 1996, pp. 1-11
Kaposi's sarcoma (KS) is a multifocal vascular lesion characterized by
abnormal proliferation of endothelial-like KS cells linked to a prono
unced leukocyte infiltration. KS lesions contain novel herpes-like DNA
sequences, KSHV, hypothesized to originate from the viral pathogen fo
r KS. Using cultured KS cells that retain the KSHV sequences, diverse
signals, including tumor necrosis factor alpha, interleukin (IL) 1 bet
a, polyinosinic acid/polycytidylic acid, and lipopolysaccharide, induc
ed the expression of the cytokine IL-6 and cellular adhesion molecules
involved in leukocyte recruitment, including vascular adhesion molecu
le 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). The thio
l-antioxidant pyrrolidine dithiocarbamate (PDTC) selectively inhibited
>90% of the activation of nuclear factor KB-like DNA binding activity
in KS cells. PDTC also reduced by >85% induced levels of VCAM-1 and I
L-6 at the mRNA, protein, and functional levels in KS cells. In contra
st, PDTC did not inhibit the induced expression of either ICAM-1 or E-
selectin. These studies show that PDTC differentially modulates the ex
pression of inflammatory response genes in KS cells that contain KSHV,
suggesting that reduction-oxidation-sensitive events are involved in
the regulation of these genes. These studies also suggest that thiol-a
ntioxidants such as PDTC may play a potentially therapeutic role in th
e treatment of KS by preventing induction of specific inflammatory res
ponse genes that may be involved in the pathogenesis of KS.